Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections
Status:
Recruiting
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy of an integrated outpatient treatment model for persons
with opioid use disorder and injection related infections. The investigators hypothesize that
outpatient antibiotic treatment coupled with comprehensive treatment for opioid use disorder
will demonstrate a safe and effective way to manage patients. Results could improve the
current protocols for the treatment of individuals with opioid use disorder and severe
infections.
Phase:
Phase 2
Details
Lead Sponsor:
Laura Fanucchi
Treatments:
Anti-Bacterial Agents Antibiotics, Antitubercular Buprenorphine Buprenorphine, Naloxone Drug Combination